122 related articles for article (PubMed ID: 38219060)
1. Short-term autophagy inhibition by autophinib or SAR405 does not alter the effect of cisplatin on ATP production in prostate cancer cells.
Kratochvilova M; Stepka P; Raudenska M; Balvan J; Richtera L; Cernei N; Skopalova DS; Zitka O; Filipensky P; Babula P; Masarik M
Bratisl Lek Listy; 2024; 124(2):84-91. PubMed ID: 38219060
[TBL] [Abstract][Full Text] [Related]
2. Autophagy is essential for the maintenance of amino acids and ATP levels during acute amino acid starvation in MDAMB231 cells.
Thomas M; Davis T; Loos B; Sishi B; Huisamen B; Strijdom H; Engelbrecht AM
Cell Biochem Funct; 2018 Mar; 36(2):65-79. PubMed ID: 29399832
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
4. The depletion of cellular ATP by AG2034 mediates cell death or cytostasis in a hypoxanthine-dependent manner in human prostate cancer cells.
Obajimi O; Melera PW
Cancer Chemother Pharmacol; 2008 Jul; 62(2):215-26. PubMed ID: 17896107
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of CFTR enhances sensitivity of prostate cancer cells to cisplatin via inhibition of autophagy.
Zhu Q; Li H; Liu Y; Jiang L
Neoplasma; 2017; 64(5):709-717. PubMed ID: 28592122
[TBL] [Abstract][Full Text] [Related]
6. Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism.
Yeon A; You S; Kim M; Gupta A; Park MH; Weisenberger DJ; Liang G; Kim J
Theranostics; 2018; 8(16):4520-4534. PubMed ID: 30214636
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of probenecid on three-dimensional cultures of prostate cancer cells.
Uwada J; Mukai S; Terada N; Nakazawa H; Islam MS; Nagai T; Fujii M; Yamasaki K; Taniguchi T; Kamoto T; Yazawa T
Life Sci; 2021 Aug; 278():119554. PubMed ID: 33932444
[TBL] [Abstract][Full Text] [Related]
8. SAR405, a PIK3C3/Vps34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells.
Pasquier B
Autophagy; 2015 Apr; 11(4):725-6. PubMed ID: 25905679
[TBL] [Abstract][Full Text] [Related]
9. Ambra1 induces autophagy and desensitizes human prostate cancer cells to cisplatin.
Liu J; Chen Z; Guo J; Wang L; Liu X
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 29101240
[TBL] [Abstract][Full Text] [Related]
10. The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells.
Jeon JY; Kim SW; Park KC; Yun M
BMC Cancer; 2015 Sep; 15():623. PubMed ID: 26345371
[TBL] [Abstract][Full Text] [Related]
11. Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.
Lee JS; Lee H; Jang H; Woo SM; Park JB; Lee SH; Kang JH; Kim HY; Song J; Kim SY
Cells; 2020 Sep; 9(9):. PubMed ID: 32883024
[TBL] [Abstract][Full Text] [Related]
12. Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363.
Lamoureux F; Thomas C; Crafter C; Kumano M; Zhang F; Davies BR; Gleave ME; Zoubeidi A
Clin Cancer Res; 2013 Feb; 19(4):833-44. PubMed ID: 23258740
[TBL] [Abstract][Full Text] [Related]
13. ATP-driven and AMPK-independent autophagy in an early branching eukaryotic parasite.
Li FJ; Xu ZS; Soo AD; Lun ZR; He CY
Autophagy; 2017 Apr; 13(4):715-729. PubMed ID: 28121493
[TBL] [Abstract][Full Text] [Related]
14. Pannexin1 inhibits autophagy of cisplatin-resistant testicular cancer cells by mediating ATP release.
Yuan M; Yao Y; Wu D; Zhu C; Dong S; Tong X
Cell Cycle; 2022 Aug; 21(15):1651-1661. PubMed ID: 35373707
[TBL] [Abstract][Full Text] [Related]
15. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex.
Schlütermann D; Skowron MA; Berleth N; Böhler P; Deitersen J; Stuhldreier F; Wallot-Hieke N; Wu W; Peter C; Hoffmann MJ; Niegisch G; Stork B
Urol Oncol; 2018 Apr; 36(4):160.e1-160.e13. PubMed ID: 29276062
[TBL] [Abstract][Full Text] [Related]
16. 8-Farnesyloxycoumarin induces apoptosis in PC-3 prostate cancer cells by inhibition of 15-lipoxygenase-1 enzymatic activity.
Hosseinymehr M; Matin MM; Sadeghian H; Bahrami AR; Kaseb-Mojaver N
Anticancer Drugs; 2016 Oct; 27(9):854-62. PubMed ID: 27362790
[TBL] [Abstract][Full Text] [Related]
17. 2-Deoxy-D-glucose has distinct and cell line-specific effects on the survival of different cancer cells upon antitumor drug treatment.
Maximchik P; Abdrakhmanov A; Inozemtseva E; Tyurin-Kuzmin PA; Zhivotovsky B; Gogvadze V
FEBS J; 2018 Dec; 285(24):4590-4601. PubMed ID: 30375744
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells.
Miyazawa Y; Sekine Y; Oka D; Nakazawa S; Tsuji Y; Nakayama H; Suzuki K
Anticancer Res; 2023 Dec; 43(12):5377-5386. PubMed ID: 38030198
[TBL] [Abstract][Full Text] [Related]
19. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy.
Chen P; Yu J; Chalmers B; Drisko J; Yang J; Li B; Chen Q
Anticancer Drugs; 2012 Apr; 23(4):437-44. PubMed ID: 22205155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
